Important Rating: Northland Capital Maintains ValiRx PLC (LON:VAL)’s “Corporate” Rating

November 29, 2016 - By Peter Kolinski

ValiRx PLC (LON:VAL) Rating

Northland Capital reaffirmed their “Corporate” rating on shares of ValiRx PLC (LON:VAL) in a research note published on Tuesday morning.

ValiRx Plc (LON:VAL) Ratings Coverage

Out of 2 analysts covering ValiRx PLC (LON:VAL), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. ValiRx PLC has been the topic of 24 analyst reports since September 16, 2015 according to StockzIntelligence Inc. The firm earned “Corporate” rating on Thursday, July 14 by Northland Capital. As per Tuesday, September 27, the company rating was maintained by Northland Capital. The rating was maintained by Beaufort Securities with “Speculative Buy” on Thursday, August 11. The stock of ValiRx Plc (LON:VAL) earned “Speculative Buy” rating by Beaufort Securities on Wednesday, October 26. On Friday, November 20 the stock rating was maintained by Northland Capital with “Corporate”. The company was maintained on Thursday, July 28 by Northland Capital. The firm earned “Corporate” rating on Wednesday, September 16 by Northland Capital. Northland Capital maintained ValiRx Plc (LON:VAL) on Tuesday, November 29 with “Corporate” rating. The firm has “Corporate” rating by Northland Capital given on Friday, April 29. Northland Capital maintained the stock with “Corporate” rating in Thursday, August 11 report.

About 491,446 shares traded hands. ValiRx Plc (LON:VAL) has declined 38.75% since April 29, 2016 and is downtrending. It has underperformed by 44.01% the S&P500.

Insitutional Activity: The institutional sentiment decreased to 1.08 in 2016 Q2. Its down 0.09, from 1.17 in 2016Q1. The ratio turned negative, as 39 funds sold all ValiRx Plc shares owned while 101 reduced positions. 59 funds bought stakes while 105 increased positions. They now own 55.26 million shares or 3.65% less from 57.35 million shares in 2016Q1.

Cap Research Glob Invsts holds 0.03% of its portfolio in ValiRx Plc (LON:VAL) for 690,276 shares. Jasper Ridge Prtn L P has 734,573 shares for 5.57% of their US portfolio. Ibm Retirement Fund accumulated 8,175 shares or 0.03% of the stock. Edge Asset Management accumulated 0.03% or 35,046 shares. Apg Asset Management Nv, a Netherlands-based fund reported 3,700 shares. Credit Suisse Ag has 1.44 million shares for 0.17% of their US portfolio. The Georgia-based Invesco Limited has invested 0% in ValiRx Plc (LON:VAL). Mizuho Asset Mngmt Coltd last reported 1,021 shares in the company. Havens Advsr Lc holds 50,000 shares or 4.1% of its portfolio. Outfitter Advisors Ltd accumulated 0.94% or 20,372 shares. Park National Oh accumulated 0.11% or 15,376 shares. Westchester Ltd Llc has invested 3.21% of its portfolio in ValiRx Plc (LON:VAL). Wells Fargo & Comm Mn holds 0.01% or 157,029 shares in its portfolio. Gabelli Funds Limited Liability owns 505,950 shares or 0.32% of their US portfolio. The United Kingdom-based Blackrock has invested 0.02% in ValiRx Plc (LON:VAL).

ValiRx plc is a biopharmaceutical company. The company has a market cap of 5.75 million GBP. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It currently has negative earnings. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis.

According to Zacks Investment Research, “The Valspar Corporation is a global leader in the paint and coatings industry, with a broad range of products including industrial, architectural, packaging, automotive refinish and floor coatings, and specialty polymers and colorants. Valspar Corporation is one of the largest global coatings manufacturers in the world, providing coatings and coating intermediates to a wide variety of customers. Valspar has been dedicated to bringing customers the latest innovations, the finest quality, and the best customer service in the coatings industry. Valspar is in a truly unique position to supply customers with the coating solutions they need.”

VAL Company Profile

The Valspar Corporation, incorporated on December 3, 1934, is engaged in developing, manufacturing and distributing a range of coatings, paints and related products. The Firm operates through two divisions: Coatings and Paints. The Firm makes and sells specialty polymers and colorants. The Firm also sells furniture protection plans, and furniture care and repair products under the Guardsman brand.

Another recent and important ValiRx Plc (LON:VAL) news was published by which published an article titled: “-LSE Ticker: WWYSP4/ISIN: GB00BWWYSP41” on March 17, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News